LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 39.71 | 21.74 | 1111 | 3084 | 0.3602 | 0.7338 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.68 | 21.74 | 986 | 3418 | 0.2884 | 0.6867 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.68 | 21.74 | 1006 | 3418 | 0.2943 | 0.6913 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.68 | 21.74 | 1103 | 3418 | 0.3226 | 0.7128 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.68 | 21.74 | 1137 | 3418 | 0.3326 | 0.7199 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 43.65 | 21.74 | 1004 | 3754 | 0.2674 | 0.6748 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 43.65 | 21.74 | 1021 | 3754 | 0.2720 | 0.6786 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 43.65 | 21.74 | 1088 | 3754 | 0.2898 | 0.6930 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 43.65 | 21.74 | 1112 | 3754 | 0.2962 | 0.6980 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 45.62 | 21.74 | 999 | 4150 | 0.2407 | 0.6573 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 45.62 | 21.74 | 1016 | 4150 | 0.2448 | 0.6610 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 45.62 | 21.74 | 1093 | 4150 | 0.2633 | 0.6771 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 45.62 | 21.74 | 1121 | 4150 | 0.2701 | 0.6827 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.59 | 21.74 | 1001 | 4492 | 0.2228 | 0.6453 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.59 | 21.74 | 1021 | 4492 | 0.2273 | 0.6496 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.59 | 21.74 | 1110 | 4492 | 0.2471 | 0.6676 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.59 | 21.74 | 1135 | 4492 | 0.2527 | 0.6724 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.56 | 21.74 | 1006 | 4838 | 0.2079 | 0.6351 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.56 | 21.74 | 1023 | 4838 | 0.2114 | 0.6387 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.56 | 21.74 | 1097 | 4838 | 0.2267 | 0.6534 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.56 | 21.74 | 1117 | 4838 | 0.2308 | 0.6572 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 51.53 | 21.74 | 1003 | 5150 | 0.1947 | 0.6254 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 51.53 | 21.74 | 1023 | 5150 | 0.1986 | 0.6294 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 51.53 | 21.74 | 1117 | 5150 | 0.2169 | 0.6477 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 51.53 | 21.74 | 1136 | 5150 | 0.2206 | 0.6512 | MN20160310_N01 | H10 |